-
-
-
-
-
-
-
Advancements in Novel Immunotherapeutics in The Oncology Battle
-
-
-
-
-
-
-
TuHURA Biosciences (HURA) Misses Q3 EPS by 14c
-
-
-
-
-
-
-
TuHURA Biosciences (HURA) and Kineta (KANT) Receive Stockholders Approval of Proposed Merger and All Related Proposals
-
-
-
-
-
-
-
TuHURA Biosciences (HURA) Appoints Dr. Bertrand Le Bourdonnec as Executive Vice President, Head of Drug Discovery, Early Development, and Program Management
-
-
-
-
-
-
-
TuHURA Biosciences (HURA) Enters into Definitive Merger Agreement to Acquire Kineta, Inc.
-
-
-
-
-
-
-
TuHURA Biosciences Completes Merger Transaction with Kintara Therapeutics
458,121 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

